Global Animal Vaccine Adjuvant Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Animal Vaccine Adjuvant Market Insights, Forecast to 2034
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combinationthese are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
Market Analysis and InsightsGlobal Animal Vaccine Adjuvant Market
Global Animal Vaccine Adjuvant market is expected to reach to US$ 350 million in 2023, with a positive growth of %, compared with US$ 330 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Animal Vaccine Adjuvant industry is evaluated to reach US$ 496.5 million in 2033. The CAGR will be 6.0% during 2023 to 2033.
Globally, dog and cat ownership is gaining popularity, especially after the pandemic. Such an increase in the rate of pet ownership across the world is expected to boost the market's growth. The increasing animal health expenditure by owners to ensure better diagnosis and treatment and increasing pet ownership are expected to positively impact the veterinary vaccine adjuvants market.
Report Covers
This report presents an overview of global Animal Vaccine Adjuvant market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Animal Vaccine Adjuvant market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Croda
SEPPIC
SDA BIO
SPI Pharma
MVP Laboratories
Zhuoyue
Zhiju Bio
Segment by Type
Oral
Subcutaneous
Intramuscular
Others
Livestock Vaccines
Companion Animals Vaccines
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Animal Vaccine Adjuvant introduction, etc. Animal Vaccine Adjuvant Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Animal Vaccine Adjuvant
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Animal Vaccine Adjuvant Market
Global Animal Vaccine Adjuvant market is expected to reach to US$ 350 million in 2023, with a positive growth of %, compared with US$ 330 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Animal Vaccine Adjuvant industry is evaluated to reach US$ 496.5 million in 2033. The CAGR will be 6.0% during 2023 to 2033.
Globally, dog and cat ownership is gaining popularity, especially after the pandemic. Such an increase in the rate of pet ownership across the world is expected to boost the market's growth. The increasing animal health expenditure by owners to ensure better diagnosis and treatment and increasing pet ownership are expected to positively impact the veterinary vaccine adjuvants market.
Report Covers
This report presents an overview of global Animal Vaccine Adjuvant market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Animal Vaccine Adjuvant market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Croda
SEPPIC
SDA BIO
SPI Pharma
MVP Laboratories
Zhuoyue
Zhiju Bio
Segment by Type
Oral
Subcutaneous
Intramuscular
Others
Segment by Application
Livestock Vaccines
Companion Animals Vaccines
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Animal Vaccine Adjuvant introduction, etc. Animal Vaccine Adjuvant Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Animal Vaccine Adjuvant
Chapter 13Methodology and Data Sources adopted by MRAResearch